Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News
  • Published:

IPOs: the narrow window closes?

Nature Biotechnology volume 22, page 1489 (2004)Cite this article

The climate for listing on US stock exchanges is less favorable as 2004 reaches its end.

Access through your institution
Buy or subscribe

This is a preview of subscription content, access via your institution

Access options

Access through your institution

Buy this article

  • Purchase on SpringerLink
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1: A comparison of biotech IPOs in the past thre windows.

Author information

Authors and Affiliations

  1. San Francisco

    Stacy Lawrence

Authors
  1. Stacy Lawrence
    View author publications

    Search author on:PubMed Google Scholar

Related links

Related links

Related links in Nature Research

IPO plans sour on both sides of the pond

Biotechs await IPO 'boomlet'

Related external links

Abingworth Management

MPM Capital

Rights and permissions

Reprints and permissions

About this article

Cite this article

Lawrence, S. IPOs: the narrow window closes?. Nat Biotechnol 22, 1489 (2004). https://doi.org/10.1038/nbt1204-1489

Download citation

  • Issue date:

  • DOI: https://doi.org/10.1038/nbt1204-1489

This article is cited by

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing